Insider Transactions Reported by 18 Insiders of Crinetics Pharmaceuticals, Inc.

Symbol
CRNX on Nasdaq
Location
San Diego, CA

Insiders trading volume in the past year

Crinetics Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
PERCEPTIVE ADVISORS LLC 10%+ Owner $200,336,855 18 Apr 2022
Richard Scott Struthers President & CEO, Director $78,242,444 -$773,017 -0.98% 23 Feb 2026
Stephen F. Betz Chief Scientific Officer $8,226,136 -$3,339,230 -29% 23 Feb 2026
Ajay Madan Chief Development Officer $7,783,510 28 Feb 2022
Jeff E. Knight Chief Operating Officer $6,790,226 -$244,964 -3.5% 23 Feb 2026
Wendall Wierenga Director $3,869,984 11 Jun 2025
Tobin Schilke Chief Financial Officer $3,099,060 -$266,305 -7.9% 03 Mar 2026
Dana Pizzuti Chief Med and Dev Officer $3,009,001 -$1,996,320 -40% 01 Dec 2025
Isabel Kalofonos Chief Commercial Officer $1,939,905 -$137,500 -6.6% 23 Feb 2026
Marc Wilson Cfo $1,671,244 31 Dec 2024
Alan Seth Krasner Chief Medical Officer $1,626,857 17 Oct 2023
James Hassard Chief Commercial Officer $1,289,737 05 Jul 2024
Matthew K. Fust Director $1,021,911 -$716,000 -41% 26 Sep 2025
Coelho Rogerio Vivaldi Director $599,351 -$180,761 -23% 12 Mar 2026
Caren Deardorf Director $543,116 11 Jun 2025
Camille L. Bedrosian Director $543,116 11 Jun 2025
Weston Nichols Director $543,116 11 Jun 2025
Stephanie Okey Director $527,611 -$119,010 -18% 03 Mar 2026

Recent Insider Transactions by Companies or Individuals for Crinetics Pharmaceuticals, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Coelho Rogerio Vivaldi CRNX Common Stock Sale -23.5% $180,761 $36.15 -5,000 16,300 12 Mar 2026 Direct
Stephanie Okey CRNX Common Stock Sale -18.4% $119,010 $39.67 -3,000 13,300 03 Mar 2026 Direct
Tobin Schilke CRNX Common Stock Sale -7.91% $266,305 $39.67 -6,713 78,121 03 Mar 2026 Direct
Richard Scott Struthers CRNX Common Stock Award 17% 62,000 426,759 23 Feb 2026 Direct
Richard Scott Struthers CRNX Stock Option (Right to Buy) Award 228,000 228,000 23 Feb 2026 Direct
Tobin Schilke CRNX Common Stock Award 60.6% 32,000 84,834 23 Feb 2026 Direct
Tobin Schilke CRNX Stock Option (Right to Buy) Award 50,000 50,000 23 Feb 2026 Direct
Jeff E. Knight CRNX Common Stock Award 38.7% 34,000 121,929 23 Feb 2026 Direct
Jeff E. Knight CRNX Stock Option (Right to Buy) Award 55,000 55,000 23 Feb 2026 Direct
Stephen F. Betz CRNX Common Stock Award 25.5% 30,000 147,713 23 Feb 2026 Direct
Stephen F. Betz CRNX Stock Option (Right to Buy) Award 47,000 47,000 23 Feb 2026 Direct
Isabel Kalofonos CRNX Common Stock Award 4076.7% 34,000 34,834 23 Feb 2026 Direct
Isabel Kalofonos CRNX Stock Option (Right to Buy) Award 55,000 55,000 23 Feb 2026 Direct
Isabel Kalofonos CRNX Common Stock Sale -75% $137,500 $55.00 -2,500 834 05 Jan 2026 Direct
Isabel Kalofonos CRNX Common Stock Options Exercise 299.8% 2,500 3,334 05 Jan 2026 Direct
Isabel Kalofonos CRNX Stock Option (Right to Buy) Options Exercise -2.5% -2,500 97,500 05 Jan 2026 Direct
Stephen F. Betz CRNX Common Stock Options Exercise 18% 18,000 117,713 26 Dec 2025 Direct
Stephen F. Betz CRNX Stock Option (Right to Buy) Options Exercise -16.6% -18,000 90,514 26 Dec 2025 Direct
Richard Scott Struthers CRNX Common Stock Options Exercise 14% 44,742 364,759 18 Dec 2025 Direct
Richard Scott Struthers CRNX Stock Option (Right to Buy) Options Exercise -100% -44,742 0 18 Dec 2025 Direct
Dana Pizzuti CRNX Common Stock Sale -6.96% $225,100 $45.02 -5,000 66,837 01 Dec 2025 Direct
Dana Pizzuti CRNX Common Stock Options Exercise 7.48% 5,000 71,837 01 Dec 2025 Direct
Dana Pizzuti CRNX Stock Option (Right to Buy) Options Exercise -6.75% -5,000 69,042 01 Dec 2025 Direct
Dana Pizzuti CRNX Common Stock Sale -7.02% $213,312 $42.66 -5,000 66,270 03 Nov 2025 Direct
Dana Pizzuti CRNX Common Stock Options Exercise 7.54% 5,000 71,270 03 Nov 2025 Direct
Dana Pizzuti CRNX Stock Option (Right to Buy) Options Exercise -6.33% -5,000 74,042 03 Nov 2025 Direct
Dana Pizzuti CRNX Common Stock Sale -7.02% $209,050 $41.81 -5,000 66,270 01 Oct 2025 Direct
Dana Pizzuti CRNX Common Stock Options Exercise 7.54% 5,000 71,270 01 Oct 2025 Direct
Dana Pizzuti CRNX Stock Option (Right to Buy) Options Exercise -5.95% -5,000 79,042 01 Oct 2025 Direct
Richard Scott Struthers CRNX Common Stock Sale -3.64% $180,000 $45.00 -4,000 106,000 26 Sep 2025 By Family Trust 2
Matthew K. Fust CRNX Common Stock Sale -41.2% $716,000 $44.75 -16,000 22,836 26 Sep 2025 Direct
Matthew K. Fust CRNX Common Stock Options Exercise 34.7% 10,000 38,836 26 Sep 2025 Direct
Matthew K. Fust CRNX Stock Option (Right to Buy) Options Exercise -82.7% -10,000 2,092 26 Sep 2025 Direct
Dana Pizzuti CRNX Common Stock Sale -4.94% $160,500 $32.10 -5,000 96,270 02 Sep 2025 Direct
Dana Pizzuti CRNX Common Stock Options Exercise 5.19% 5,000 101,270 02 Sep 2025 Direct
Dana Pizzuti CRNX Stock Option (Right to Buy) Options Exercise -5.62% -5,000 84,042 02 Sep 2025 Direct
Dana Pizzuti CRNX Common Stock Sale -31.2% $912,900 $30.43 -30,000 66,270 22 Aug 2025 Direct
Dana Pizzuti CRNX Common Stock Options Exercise 45.3% 30,000 96,270 22 Aug 2025 Direct
Dana Pizzuti CRNX Stock Option (Right to Buy) Options Exercise -25.2% -30,000 89,042 22 Aug 2025 Direct
Dana Pizzuti CRNX Common Stock Sale -8.92% $189,437 $29.18 -6,492 66,270 20 Aug 2025 Direct
Stephen F. Betz CRNX Common Stock Sale -49.4% $3,141,877 $32.23 -97,483 99,713 12 Jun 2025 Direct
Stephen F. Betz CRNX Common Stock Options Exercise 80.9% 88,170 197,196 12 Jun 2025 Direct
Stephen F. Betz CRNX Stock Option (Right to Buy) Options Exercise -60.2% -88,170 58,198 12 Jun 2025 Direct
Caren Deardorf CRNX Common Stock Award 73.4% 6,900 16,300 11 Jun 2025 Direct
Caren Deardorf CRNX Stock Option (right to buy) Award 10,350 10,350 11 Jun 2025 Direct
Stephanie Okey CRNX Common Stock Award 73.4% 6,900 16,300 11 Jun 2025 Direct
Stephanie Okey CRNX Stock Option (right to buy) Award 10,350 10,350 11 Jun 2025 Direct
Coelho Rogerio Vivaldi CRNX Common Stock Award 47.9% 6,900 21,300 11 Jun 2025 Direct
Coelho Rogerio Vivaldi CRNX Stock Option (right to buy) Award 10,350 10,350 11 Jun 2025 Direct
Matthew K. Fust CRNX Common Stock Award 31.5% 6,900 28,836 11 Jun 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.